百克生物
(688276)
| 流通市值：99.86亿 | | | 总市值：99.86亿 |
| 流通股本：4.14亿 | | | 总股本：4.14亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 162,290,516.78 | 1,229,084,097.15 | 1,026,012,316.59 | 618,401,246.78 |
| 营业收入 | 162,290,516.78 | 1,229,084,097.15 | 1,026,012,316.59 | 618,401,246.78 |
| 二、营业总成本 | 167,225,569.52 | 929,411,066.43 | 731,232,689.54 | 457,900,552.96 |
| 营业成本 | 23,911,867.74 | 179,178,525.61 | 148,820,498.48 | 74,759,645.7 |
| 税金及附加 | 1,920,768.34 | 9,969,603.18 | 7,920,695.64 | 4,833,772.06 |
| 销售费用 | 73,607,698.35 | 474,960,286.31 | 380,401,013.16 | 233,197,729.51 |
| 管理费用 | 30,714,832.48 | 112,929,752.77 | 80,829,231.42 | 62,407,627.08 |
| 研发费用 | 36,858,462.61 | 156,141,989.57 | 116,503,270.72 | 85,529,937.9 |
| 财务费用 | 211,940 | -3,769,091.01 | -3,242,019.88 | -2,828,159.29 |
| 其中:利息费用 | 558,656.63 | 1,518,736.6 | 1,311,400.22 | 882,076.64 |
| 其中:利息收入 | 417,374.55 | 4,598,072.1 | 4,057,733.52 | 3,124,184.71 |
| 加:投资收益 | -6,783,077.71 | -440,272.56 | -172,138.94 | 226,204.61 |
| 资产处置收益 | - | 2,769.37 | - | - |
| 资产减值损失(新) | - | -39,951,282.53 | -4,152,957.4 | 10,102,781.61 |
| 信用减值损失(新) | 2,708,055.63 | -6,200,966.72 | -10,513,087.14 | -14,714,768.73 |
| 其他收益 | 549,451.79 | 4,805,754.67 | 3,766,132.68 | 2,444,390.45 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -8,460,623.03 | 257,889,032.95 | 283,707,576.25 | 158,559,301.76 |
| 加:营业外收入 | 5,153,088.56 | 4,895,889.02 | 433,711.2 | 413,463.54 |
| 减:营业外支出 | 163,098.61 | 7,012,011.05 | 4,787,554.68 | 154,210.45 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -3,470,633.08 | 255,772,910.92 | 279,353,732.77 | 158,818,554.85 |
| 减:所得税费用 | -4,534,908.86 | 23,679,085.19 | 34,983,913.35 | 21,214,058.19 |
| 六、净利润 | 1,064,275.78 | 232,093,825.73 | 244,369,819.42 | 137,604,496.66 |
| 持续经营净利润 | 1,064,275.78 | 232,093,825.73 | 244,369,819.42 | 137,604,496.66 |
| 归属于母公司股东的净利润 | 1,064,275.78 | 232,093,825.73 | 244,369,819.42 | 137,604,496.66 |
| (一)基本每股收益 | 0 | 0.56 | 0.59 | 0.33 |
| (二)稀释每股收益 | 0 | 0.56 | 0.59 | 0.33 |
| 八、其他综合收益 | -4,619,106.08 | 6,594,931.27 | -20,762,963.79 | -13,105,656.02 |
| 归属于母公司股东的其他综合收益 | -4,619,106.08 | 6,594,931.27 | -20,762,963.79 | -13,105,656.02 |
| 九、综合收益总额 | -3,554,830.3 | 238,688,757 | 223,606,855.63 | 124,498,840.64 |
| 归属于母公司股东的综合收益总额 | -3,554,830.3 | 238,688,757 | 223,606,855.63 | 124,498,840.64 |
| 公告日期 | 2025-04-21 | 2025-04-21 | 2024-10-26 | 2024-08-16 |
| 审计意见(境内) | | 标准无保留意见 | | |